New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes

ReachMD Healthcare Image
Media formats available:
Details
Presenters
Comments
  • Overview

    Women with post-traumatic stress disorder (PTSD) suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Unfortunately, many women are not screened for PTSD. If they are diagnosed, they often see little benefit from currently available treatments. Drs. Joseph Goldberg and Roger McIntyre discuss the root causes for these deficits and provide clinicians with key action steps to take to improve outcomes for their patients affected by PTSD. Join us! 

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty: 
    Joseph F. Goldberg, MD
    Clinical Professor of Psychiatry
    Icahn School of Medicine at Mount Sinai
    New York, NY

    Dr. Goldberg has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Receives royalties: American Psychiatric Publishing, Cambridge University Press
    Consulting Fees: Genomind, Intra-Cellular Therapies, Luye Pharmaceuticals, Neumora, Neurelis, Otsuka, Sage Pharmaceuticals, Sunovion, Supernus
    Speakers bureau: AbbVie, Alkermes, Axsome, Bristol Myers Squibb

    Roger McIntyre, MD
    Professor of Psychiatry and Pharmacology
    University of Toronto
    Toronto, Canada

    Dr. McIntyre has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Research: CIHR/GACD/National Natural Science Foundation of China (NSFC), Milken Institute
    Consulting Fees: AbbVie, Alkermes, atai Life Sciences, Axsome, Bausch Health, Biogen, Boehringer Ingelheim, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris
    CEO: Braxia Scientific Corp.

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Barry Fiedel has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Utilize validated guideline-recommended screening tools to diagnose post-traumatic stress disorder (PTSD) in women
    • Incorporate PTSD treatment guidelines into clinical practice to ensure evidence-based management
    • Evaluate the inadequacies and risks associated with off-label treatments for PTSD
    • Explain the link between the pathophysiology of PTSD and the pharmacological rationale for treatment
    • Discuss new and emerging therapies and how they fit into the clinical management of PTSD
  • Target Audience

    This activity has been designed to meet the educational needs of ob-gyns, primary care physicians and psychiatrists, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with post-traumatic stress disorder (PTSD).

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .75 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credits. Approval is valid until November 26, 2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .75 contact hours/0.075 CEUs of pharmacy contact hours.

    The Universal Activity Number for this program is JA0006235-0000-24-131-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Otsuka America Pharmaceutical Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying Omnia Education…
but how about a more personalized experience?

Register for free